Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)

SHA:603392 Revenue

Beijing Wantai Biological Pharmacy Enterprise had revenue of 582.07M CNY in the quarter ending September 30, 2024, a decrease of -27.72%. This brings the company's revenue in the last twelve months to 2.49B, down -66.82% year-over-year. In the year 2023, Beijing Wantai Biological Pharmacy Enterprise had annual revenue of 5.51B, down -50.73%.

• Revenue (ttm): 2.49B
• Revenue Growth: -66.82%
• P/S Ratio: 33.91
• Revenue / Employee: 647.93K
• Employees: 3,843
• Market Cap: 84.51B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	5.51B	-5.67B	-50.73%
Dec 31, 2022	11.19B	5.43B	94.51%
Dec 31, 2021	5.75B	3.40B	144.25%
Dec 31, 2020	2.35B	1.17B	98.88%
Dec 31, 2019	1.18B	201.07M	20.46%